Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
ALNYAlnylam Pharma
$182.10
$5.51 (3.12%)

Alnylam Pharma Similar Stocks

Comparison Results

Name
Price
Price Target Upside
Market Cap
PE Ratio
Yearly Gain
Analyst Consensus
Best Analyst Price Target
Smart Score
Follow
ALNYAlnylam Pharma
$172.09
$20.76B
-23.60
14.42%
7Buy
5Hold
0Sell
Moderate Buy
premium
premium
ARWRArrowhead Pharmaceuticals
$91.17
$7.12B
-61.60
54.33%
6Buy
2Hold
0Sell
Strong Buy
premium
premium
BNTCBenitec Biopharma
$29.99M
-0.50
-52.21%
premium
premium
SNYSanofi-Aventis Sa
$130.41B
8.80
1.13%
premium
premium
RGLSRegulus
$1.50
$53.83M
-2.10
-14.29%
1Buy
1Hold
0Sell
Moderate Buy
premium
premium
ABUSArbutus Biopharma
$5.33
$273.14M
-2.80
-30.69%
4Buy
1Hold
0Sell
Strong Buy
premium
premium

Performance Comparison

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis